Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L).
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution.
For the quantitative determination of total glucose in serum.
Glucose reagent is used for the quantitative determination of glucose in human serum.
Medicine Products:(Date:10/15/2008)...n chosen as the newest recipients of the prestigio...l work. The program is funded by the John A. Hart...cal Society of America , and directed by James Lub...ellows receives a $50,000 dissertation grant plus ...utions, which enables recipients to more fully con...
(Date:10/15/2008)...irstCall/ -- Exponent, Inc.,(Nasdaq: EXPO ) today...ended,September 26, 2008., For the third quarter ...00, as compared to $48,904,000, in the same period... 15% to $51,751,000, as compared to,$44,916,000, l...$0.38 per,diluted share, as compared to $5,037,000...
(Date:10/15/2008)...f epic proportions is Get off the Dime: The Se...EW YORK, Oct. 15 /PRNewswire/ --, "Dr. Potarazu,s...on of, empowering patients and employers, by usin... and integrating social networking, can truly,revo... fails to one that works.", ...
(Date:10/15/2008)...irstCall/ -- deCODE genetics,(Nasdaq: DCGN ) toda...iew of,its long-term business strategy. Over the p... in medicinal chemistry, structural biology and,hu...roperty portfolios in,both therapeutics and DNA-ba... is to optimize the value of these assets for its ...
Breaking Medicine News(10 mins):Health News:The Gerontological Society of America congratulates new Hartford Doctoral Fellows 2Health News:Exponent Reports Third Quarter 2008 Results 2Health News:Exponent Reports Third Quarter 2008 Results 3Health News:Exponent Reports Third Quarter 2008 Results 4Health News:Exponent Reports Third Quarter 2008 Results 5Health News:Exponent Reports Third Quarter 2008 Results 6Health News:Exponent Reports Third Quarter 2008 Results 7Health News:Exponent Reports Third Quarter 2008 Results 8Health News:With the Economy of the United States at a Turning Point, Health Care Could Be Our Next Serious Crisis ... 2Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 2Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 3Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 4(Date:10/13/2008)...nding advances study Study needed because of...Oct. 13 /- Advanced Circulatory Syste...nounced today that it has received,an additional $...s of,Health (NIH) to continue a study testing two ...e cardiac arrest outside a hospital. Whatcom Count...
(Date:10/13/2008)... -- Neuronascent, Inc.,( http://www.neuronascent.c...,funding from multiple sources to further the deve...ng Alzheimer,s disease, depression and,ischemia. N...aryland,Department of Business and Economic Develo...trial Partnerships in collaboration with Universit...
(Date:10/13/2008)...gher Sensitivity and Specificity, than Other Rapi...ferred test in all phases of this ...wire/ -- AT First Diagnostic LLC an,emerging world...s, today,announced that a recent evaluation conduc...of the FirstVue(TM) HBSAG Test, was released at th...
(Date:10/13/2008)...Cancer Populations Facilitates ...3 /- Rubicon Genomics, Inc. today,ann... DNA samples for The,Cancer Atlas Genome Project.,...ndardize total genomic,DNA from 3,000 tissue and b...omePlex(TM) Whole Genome Amplification technology ...
Breaking Medicine Technology:Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Internews Enlists More Than 1 000 Journalists in Fight Against HIV AIDS 26261 1Internews Enlists More Than 1 000 Journalists in Fight Against HIV AIDS 26261 2Fitness Model Entrepreneur Targets Childhood Obesity and Makes Headlines Nationwide With New Franchise Offering 26259 1Fitness Model Entrepreneur Targets Childhood Obesity and Makes Headlines Nationwide With New Franchise Offering 26259 2Guardian Survey 3A Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses 26257 1Guardian Survey 3A Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses 26257 2Guardian Survey 3A Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses 26257 3Guardian Survey 3A Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses 26257 4Guardian Survey 3A Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses 26257 5Guardian Survey 3A Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses 26257 6Beckman Coulter Investor Events Second Half of 2008 7610 1Beckman Coulter Investor Events Second Half of 2008 7610 2... 10, 2007 - According to,The Waismann Method 2006 ...ondents seeking treatment for opiate dependency ha...in, OxyContin, Percocet,and Fentanyl were among th...ers who reported a dependency said they suffered f...tered addiction,specialist for the Waismann Method...
...sense,Pharma, a German biopharmaceutical company s...ors, today announced, that data from the,Phase IIb...presented at the 43rd Annual Meeting of the Americ... be held in Chicago, Illinois,U.S.A, from June 1s...ing Phase,IIb-trial adult patients with recurrent ...
Other Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 3